CompletedPhase IInterventional

Deferred registration: Quotient Sciences Code: QSC302976

This clinical trial is an early Phase 1 study run by Quotient Sciences in the UK. Phase 1 trials are the very first step in testing a potential new medicine in humans. Rather than treating an illness, these studies involve healthy volunteers to find out how safe a medicine is, whether it causes side effects, and how it moves through the human body. At this time, specific scientific details about the medicine have been temporarily deferred. This is a standard process in early medical research that allows companies to protect new research data for a short period before making everything public. The study has confirmed that it is looking for healthy men aged between 30 and 65. Taking part helps doctors and scientists gather vital safety information before medicines are tested in patients who have specific illnesses.

At a glance

Status

Completed

Phase

Phase I

Sponsor

Epygenix Therapeutics, Inc.

Enrolment target

Start

11 Aug 2026

Estimated completion

17 Sep 2026

Healthy volunteers

What is this study about?

Medical research moves through several steps, known as phases. This study is a Phase 1 clinical trial, which means scientists are testing a new treatment in human volunteers for the first time. Before any new drug can be used to treat patients with health conditions, researchers must first make sure it is safe and understand how the body breaks it down. Healthy volunteers play an essential role in this process.

You may notice that the exact name and purpose of the medicine are not detailed yet. In the UK, early trials can apply for 'deferred registration.' This temporary delay protects commercial research while the study is set up. Even though full details are not yet public, the trial must still follow strict UK safety regulations and receive independent ethical approval before any testing begins.

The study is being carried out by Quotient Sciences, a specialist medical research company. It is designed specifically for healthy adult men aged between 30 and 65. Every medicine currently prescribed on the NHS had to pass through an early Phase 1 safety study just like this one, making healthy volunteers a crucial part of developing future treatments.

Key takeaways

This is an early-stage Phase 1 trial focused on testing the safety of a new medicine.
The trial is open to healthy men aged between 30 and 65.
Detailed scientific information has been temporarily deferred under standard UK research rules.
Participants will be closely looked after by qualified doctors and nurses at a research clinic.
Taking part is completely voluntary, and you can change your mind at any time.

Who may be eligible?

This trial is specifically looking for healthy male volunteers who are between 30 and 65 years old.

Because detailed criteria are temporarily withheld, the exact health requirements have not yet been published. However, Phase 1 studies in healthy volunteers generally require you to be in good everyday health, free from long-term illnesses such as diabetes or heart conditions, and not taking regular prescription medications.

If you are interested, the research team will carry out standard medical checks—such as blood tests and blood pressure measurements—to confirm whether you are safe and suitable to take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

I am a man aged between 30 and 65.
I consider myself to be in good overall health.
I do not have major long-term illnesses (such as heart disease or diabetes).
I am not taking regular prescription medicines.
I am able to attend appointments at a specialist research clinic.

Answer every question to see your result.

What does participation involve?

While the exact timetable for this trial has not yet been released, Phase 1 studies follow a clear and structured routine. Taking part usually begins with a screening appointment where the medical team checks your general health, takes blood samples, and checks your heart rhythm. If you qualify, you will visit a specialist clinical unit to receive a dose of the study medicine. Some trials require a short stay at the clinic so the medical staff can monitor you closely, while others involve day visits. Throughout the study, nurses and doctors will take regular blood and urine samples to see how your body handles the medicine. You will also have a final follow-up visit to ensure you remain well.

Potential risks and benefits

Phase 1 trials do not offer direct health benefits because the treatment is not intended to cure an existing illness, although participants often find it rewarding to help develop new treatments. As with any new medicine, there are possible risks and side effects, which the study team will explain in detail before you agree to join. You will be monitored closely by experienced medical staff throughout your time on the trial. Taking part is entirely voluntary, and you have the right to withdraw at any time without having to give a reason and without it affecting your usual NHS care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Quotient Sciences Limited
City only
Nottingham, England

Common questions

Why are the full details of this study hidden for now?

Under UK rules, early Phase 1 studies can briefly delay publishing certain details to protect research ideas. Regulators and ethics committees still review all safety details before the study starts.

Who can take part in this study?

The trial is looking for healthy men between the ages of 30 and 65 who do not have major medical conditions.

Will I be paid for taking part?

Clinical trials involving healthy volunteers in the UK typically provide financial compensation to cover your time, travel, and inconvenience.

Do I need a GP referral to join?

No, you do not need a GP referral to express interest, but the study doctors will usually contact your GP to confirm your medical history.

What happens if I decide I want to stop?

You are free to leave the trial at any point. Your safety will still be checked, and your normal healthcare will never be affected.

How to find out more

Robert Faulkner

rfaulkner@harmonybiosciences.com +1 817-773-1958 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.